The proliferation of vascular smooth muscle cells (VSMCs) induced by injury to the intima of arteries is an important etiologic factor in vascular proliferative disorders such as atherosclerosis and restenosis. Uncaria rhynchophylla is traditional Chinese herb that has been applied to the treatment of convulsive disorders, such as epilepsy, in China. In the present study, we examined whether corynoxeine exerts inhibitory effects on plateletderived growth factor (PDGF)-BB-induced rat aortic VSMC proliferation and the possible mechanism of such effects. Pre-treatment of VSMCs with corynoxeine (5-50 m mM) for 24 h resulted in significant decreases in cell number without any cytotoxicity; the inhibition percentages were 25.0؎12.5, 63.0؎27.5 and 88.0؎12.5% at 5, 20 and 50 m mM, respectively. Also, corynoxeine significantly inhibited the 50 ng/ml PDGF-BB-induced DNA synthesis of VSMCs in a concentration-dependent manner without any cytotoxicity; the inhibitions were 32.8؎11.0, 51.8؎8.0 and 76.9؎7.4% at concentrations of 5, 20 and 50 m mM, respectively. Pre-incubation of VSMCs with corynoxeine significantly inhibited PDGF-BB-induced extracellular signal-regulated kinase 1/2 (ERK1/2) activation, whereas corynoxeine had no effects on mitogen-activated protein kinase (MAPK/ERK)-activating kinase 1 and 2 (MEK1/2), Akt, or phospholipase C (PLC)g g1 activation or on PDGF receptor beta (PDGF-Rb b) phosphorylation. These results suggest that corynoxeine is a potent ERK1/2 inhibitor of key PDGF-BB-induced VSMC proliferation and may be useful in the prevention and treatment of vascular diseases and restenosis after angioplasty.
Vascular smooth muscle cells (VSMCs) are the main cellular component in the arterial wall, and abnormal proliferation of VSMCs plays a central role in the pathogenesis of atherosclerosis and restenosis after angioplasty and possibly in the development of hypertension. 1) VSMCs migrate into the intima and proliferate to form a fibrous cap over a lipidrich core in atherosclerosis. 2) To prevent the proliferation and migration of VSMCs, it may be possible to influence the downstream intracellular signaling events responsible for transducing the signals from the various growth factor receptors.
3) Since platelet-derived growth factor (PDGF) is one of the principal regulators of mitogenesis in VSMCs and the expression of PDGF is increased in atherosclerotic lesions, PDGF-induced mitogenesis and proliferation are prerequisites for intimal thickening after angioplasty.
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The PDGF-BB-induced mitogenesis signaling pathway has already been relatively well characterized. The binding of PDGF-BB to PDGF receptor (PDGF-R) leads to phosphorylation of PDGF-Rb tyrosine residues. A number of signaling molecules that contain the SH2 domain, including phospholipase C (PLC)g1, phosphatidylinositol 3Ј-kinase (PI3Ј-K), and ras/raf-1, are initiated by PDGF-BB and subsequently coupled to the activation of mitogen-activated protein kinases (MAPK). 8) PDGF-BB activates the extracellular signal-regulated kinases 1 and 2 (ERK1/2) pathway by triggering ras-raf activation, MAPK/ERK activating kinase 1 and 2 (MEK1/2) phosphorylation, and ERK1/2 phosphorylation. 9) Therefore, understanding the inhibition on PDGF-BB-stimulated VSMC proliferation is important in terms of developing methods to treat cardiovascular disease.
The hook of Uncaria rhynchophylla (MIQ.) JACKS. (Rubiaceae) is a traditional Chinese herbal drug that is generally used to treat convulsive disorders such as epilepsy. The hypotensive effect of Uncaria rhynchophylla on the cardiovascular system has also been reported. 10, 11) Its vasodilatory effects are mediated primarily via release of endothelium derived relaxing factor/nitric oxide (EDRF/NO) and inhibition of voltage-dependent Ca 2ϩ influx. [12] [13] [14] Uncaria rhynchophylla also inhibits tumor necrosis factor-a (TNF-a) and nitric oxide production in BV-2 mouse microglial cells in vitro. The neuroprotective effects of Uncaria rhynchophylla following transient global ischemia have also been evaluated. 15) However, the anti-proliferative effect of corynoxeine isolated from the hook of Uncaria rhynchophylla on VSMCs remains unknown.
In this study, we investigated the effect of corynoxeine on PDGF-BB-induced VSMC proliferation. The intracellular signaling pathways responsible for the action of corynoxeine in PDGF-BB-induced VSMC proliferation were also investigated. 1 H-NMR (500 MHz, CDCl 3 ), 13 C-NMR (125 MHz, CDCl 3 ) and physical constants were identical with the previous report. 16, 17) Cell Culture Rat aortic VSMCs were isolated by enzymatic dispersion as previously described 18) according to the modified method of Chamley et al. 19) Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% FBS, 100 IU/ml penicillin, 100 mg/ml streptomycin, 8 mM HEPES, and 2 mM L-glutamine at 37°C in an incubator with a humidified atmosphere of 95% air and 5% CO 2 . The purity of VSMC culture was confirmed by immunocytochemical localization of a-smooth-muscle actin. In these experiments, VSMCs were used at passage 4-8.
MATERIALS AND METHODS

Materials
Measurement of Cell Proliferation and DNA Synthesis Cell proliferation and DNA synthesis were measured as previously described. 18) For cell counting, VSMCs were seeded in 12-well culture plates at 5-6ϫ10 4 cells/ml and cultured in DMEM with 10% FBS at 37°C for 24 h. Under these conditions, the cells reached ca. 70% confluence. The medium was then replaced by serum-free medium with corynoxeine. The cells were stimulated with 50 ng/ml PDGF-BB, then trypsinized with trypsin-EDTA and counted using a hemocytometer under a microscope. For [ 3 H]-thymidine incorporation experiments, VSMCs were seeded in 24-well culture plates 5000 cells/well and then allowed to grow for 3-4 d in DMEM, and 2 mCi/ml of [ 3 H]-thymidine were added to the medium. The reactions were terminated after 4 h by aspirating the medium and subjecting the cultures to sequential washes on ice with PBS containing 10% trichloroacetic acid and ethanol/ether (1 : 1, v/v). Acid-insoluble [ 3 H]-thymidine was extracted into 250 ml of 0.5 M NaOH/well; this solution was then mixed with 3 ml of scintillation cocktail (Ultimagold, Packard Bioscience, CT, U.S.A.) and quantified using a liquid scintillation counter (LS3801, Beckman, Düsseldorf, Germany).
Immunoblotting Immunoblotting was performed as previously described. 20) Briefly, VSMCs in 12-well plates were incubated in DMEM medium. VSMCs were pre-treated with corynoxeine for 24 h before addition of 50 ng/ml PDGF-BB for 1 min for PDGF-Rb phosphorylation, MEK1/2 phosphorylation, and ERK 1/2 phosphorylation, for 15 min for Akt phosphorylation and for 5 min for PLCg1 phosphorylation assays. Cells were lysed with SDS lysis buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 50 mM dithiothreitol (DTT) and protease inhibitor Cocktail Tablet (Roche, Mannheim, Germany). Lysates were centrifuged at 13000 g for 10 min, and the supernatants were collected. Protein concentration in the supernatant was determined using BCA Protein Assay Reagent (Pierce, Rockford, IL, U.S.A.) according to the manufacturer's protocol using bovine serum albumin (BSA) as a standard. Proteins were separated in 7.5-10% SDS polyacrylamide gel (SDS-PAGE) using a Mini-Protein II System (Bio-Rad, CA, U.S.A.). Proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Amersham Pharmacia Biotech, Buckinghamshire, U.K.) at 250 mA with transfer buffer containing 25 mM Tris-HCl, 192 mM glycine and 20% methanol (pH 8.3). PVDF membranes were blocked with 5% BSA in TBS-T at room temperature for 1 h. The membranes were washed with TBS-T and incubated overnight at 4°C with primary phospho-MEK1/2, phospho-ERK1/2, phospho-Akt, phospho-PLCg1 or phospho-PDGF-Rb primary antibodies diluted 1 : 1000 in BSA/TBS-T buffer. The membranes were washed again and incubated at 4°C for 3 h with horseradish peroxidase-conjugated anti-IgG secondary antibodies (New England Biolabs, MA, U.S.A.) diluted 1 : 5000 in BSA/TBS-T buffer. After washing, the immunoreactive proteins were detected by chemiluminescent reaction (ECL Plus kit, Amersham Pharmacia Biotech, Buckinghamshire, U.K.) and exposure of the membranes to Hyperfilm ECL (Amersham Pharmacia Biotech, Buckinghamshire, U.K.). The levels phospho-PDGF-Rb, phospho-MEK1/2, phospho-ERK1/2, phosphoAkt or phospho-PLCg1 were normalized to total PDGF-Rb, total MEK1/2, total ERK1/2, total Akt or total PLCg1 values, respectively. The band intensities were quantified using Scion-Image for Windows (Scion Corporation, MD, U.S.A.).
Statistical Analysis The experimental results were expressed as meanϮS.E.M. One-way analysis of variance (ANOVA) was used for multiple comparison (GraphPad Prism version 4.00 for Windows, San Diego, CA, U.S.A.). If there was a significant variation between treatment groups, Dunnett's test was applied. The data were considered significant with pϽ0.05.
RESULTS
Effects of Corynoxeine on the Proliferation and DNA Synthesis of Rat Aortic VSMCs
We examined the inhibitory effect of corynoxeine (Fig. 1) on the PDGF-BB-induced proliferation of VSMCs measured by directly counting cell numbers. The number of cells was significantly increased by 50 ng/ml PDGF-BB treatment for 24 h, which was in turn significantly decreased by pre-treatment with corynoxeine for 24 h in a concentration-dependent manner. The inhibitions were 25.0Ϯ12.5, 63.0Ϯ27.5 and 88.0Ϯ 12.5% at 5, 20 and 50 mM, respectively (Fig. 2A) . The effect of corynoxeine on DNA synthesis in VSMCs was also tested using [ (Fig. 2B) . Corynoxeine did not show any cytotoxic effects on cell viability as assessed by MTT and flow cytometry assays at a higher concentration (100 mM) than those used in these experiments (data not shown), suggesting that the inhibitory effects of corynoxeine on cell proliferation and DNA synthesis were not due to cytotoxicity.
Effects of Corynoxeine on PDGF-Rb b, PLCg g1, Akt, ERK1/2 and MEK1/2 Phosphorylation in VSMCs
PDGF-BB binding to PDGF-Rb is associated with dimerization, autophosphorylation, clustering and activation of PDGF receptor tyrosine kinase, 21) subsequently causing VSMC proliferation through activation of ERK1/2 and other signaling enzymes. 22) To examine the mechanism underlying the antiproliferative effect of corynoxeine, PDGF-Rb and its downstream kinases were examined in VSMCs. PDGF-BB differentially induced PDGF-Rb, MEK1/2, ERK1/2, Akt and PLCg1 phosphorylation in VSMCs in a time-dependent manner. PDGF-Rb was fully activated at 1 min after PDGF-BB stimulation, whereas MEK1/2, ERK1/2, Akt and PLCg1 were fully activated at 5 min, 10 min, 15 min and 5 min, respectively (data not shown). VSMCs were stimulated with 50 ng/ml PDGF-BB for 1 min in the presence or absence of either corynoxeine (5-50 mM) or tyrphostin AG1295 (20 mM), a selective inhibitor of PDGF-Rb phosphorylation. However, pre-treatment with corynoxeine did not significantly inhibit PDGF-Rb phosphorylation induced by PDGF-BB (Fig. 3A) . To further examine the mechanisms underlying the antiproliferative effect exerted by corynoxeine, VSMCs were stimulated with 50 ng/ml PDGF-BB in the presence or absence of corynoxeine. The effects of corynoxeine on phosphorylation of PLCg1, Akt, ERK1/2 and MEK1/2, which are implicated in signaling pathways regulated by phosphorylation of PDGF-Rb, were examined. Corynoxeine had no significant effects on PDGF-BB-induced PLCg1 (Fig. 3B) and Akt (Fig. 3C ) phosphorylation at 5, 20 and 50 mM. The phosphorylations of Akt and PLCg1 were inhibited by pre-treatment of VSMCs with LY294002 (50 mM) and U73122 (10 mM), selective inhibitors of Akt and PLCg1, respectively. However, pre-treatment with corynoxeine significantly inhibited PDGF-BB-induced ERK1/2 phosphorylation in a concentration-dependent manner by 13.4Ϯ8.8, 43.9Ϯ12.0 and 73.4Ϯ8.8% at 5, 20 and 50 mM, respectively (Fig. 3D) . We next examined whether the inhibitory effect of corynoxeine was induced by blocking phosphorylation of MEK1/2, which is upstream of ERK1/2. As shown in Fig. 4 , corynoxeine had no significant effect on PDGF-BB-induced MEK1/2 phosphorylation at 5, 20 and 50 mM.
Effects of ERK1/2 Inhibitor on the Proliferation and DNA Synthesis of VSMCs To confirm that the inhibitory effect of corynoxeine is mediated through inhibition of ERK1/2, the effect of corynoxeine on cell number and DNA synthesis was examined after treating VSMCs with 50 mM corynoxeine or 10 mM U0126 (an ERK1/2 inhibitor) for 24 h. Corynoxeine and U0126 completely inhibited the PDGF-BBinduced proliferation of VSMCs (Fig. 5A) . Also, treatment of VSMCs with corynoxeine and U0126 significantly inhibited the PDGF-BB-induced [
3 H]-thymidine incorporation (Fig. 5B) .
DISCUSSION
The present study demonstrated that corynoxeine isolated from the hook of Uncaria rhynchophylla exhibits a suppressive effect on PDGF-BB mediated VSMC proliferation and suggested that the inhibition of ERK1/2 activation is involved in the effect of this compound. 4 cells/ml and cultured in DMEM with 10% FBS at 37°C for 24 h. Under these conditions, the cells reached ca. 70% confluence. VSMCs were pre-cultured in serum-free medium in the presence and absence of corynoxeine (5-50 mM) for 24 h and then stimulated with 50 ng/ml PDGF-BB. The cells were trypsinized and counted using hemocytometer after 24 h. (B) Effect of corynoxeine on PDGF-BB-induced DNA synthesis. VSMCs were seeded in 24-well culture plates at 5000 cells/well and then allowed to grow for 3-4 d in DMEM. VSMCs were pre-cultured in serum-free medium in the presence and absence of corynoxeine (5-50 mM) for 24 h and then stimulated with 50 ng/ml PDGF-BB. [ 3 H]-Thymidine (2 mCi/ml) was added to the serum-free medium after 20 h, and then [
The Uncaria species, such as Uncaria rhynchophylla have long been used in Chinese medicine as antipyretic, antihypertensive and anticonvulsant medications for the treatment of headache, vertigo and epilepsy. 22, 23) However, the anti-proliferative effect of corynoxeine (Fig. 1) isolated from the hook of Uncaria rhynchophylla on VSMCs remains unknown. Abnormal proliferation of VSMCs plays an important role in the development and progression of proliferative cardiovascular diseases, including hypertension and atherosclerosis. [24] [25] [26] [27] Therefore, it is important to search for anti-proliferative agents as potential preventive or therapeutic agents for cardiovascular diseases such as atherosclerosis. 28) In this study, we identified that corynoxeine inhibited VSMC numbers in response to PDGF-BB with 50% inhibitory concentrations (IC 50 ) of 13.7 mM (Fig. 2A) . In the previous study, we reported the time-course of PDGF-BB-induced cell cycle progression of VSMC. The cell cycle progressions in various time-points after PDGF-BB-stimulation showed maximum cell cycle progression at 24 h. 29) Corynoxeine inhibited DNA synthesis in response to PDGF-BB (24 h) with IC 50 of 9.2 mM (Fig. 2B) . Moreover, the antiproliferative effect of corynoxeine was not due to cellular cyto- VSMCs were seeded in 6-well culture plates at 5ϫ10 4 cells/ml and cultured in DMEM with 10% FBS at 37°C for 24 h. Under these conditions, the cells reached ca. 70% confluence. Cells were pre-cultured in the presence or absence of indicated concentration of corynoxeine, AG1295 (PDGF-Rb inhibitor, 20 mM), U73122 (PLC inhibitor, 10 mM) LY294002 (Akt inhibitor, 50 mM) or U0126 (MEK1/2 inhibitor, 10 mM) in serum-free medium for 24 h, and then stimulated briefly with 50 ng/ml PDGF-BB for different time periods (A; 1 min for PDGF-Rb, B; 5 min for PLC-g1, C; 15 min for Akt, D; 10 min for ERK1/2 phosphorylation) at 37°C. The cells were lysed, and proteins were analyzed by 7.5% SDS-PAGE and immunoblotting. Total PDGF-Rb was used for normalization. After densitometric quantification, data are expressed as meanϮS.E.M. (nϭ3). * pϽ0.05, * * pϽ0.01.
Fig. 4. Effect of Corynoxeine on MEK1/2 Phosphorylation in VSMCs
VSMCs were seeded in 6-well culture plates at 5ϫ10 4 cells/ml and cultured in DMEM with 10% FBS at 37°C for 24 h. Under these conditions, the cells reached ca. 70% confluence. Cells were pre-cultured in the presence or absence of corynoxeine (5-50 mM) or U0126 (MEK1/2 inhibitor, 10 mM) in serum-free medium for 24 h and then stimulated briefly with 50 ng/ml PDGF-BB for 5 min at 37°C. The cells were lysed, and proteins were analyzed by 7.5% SDS-PAGE and immunoblotting. Total MEK1/2 was used for normalization. After densitometric quantification, data were expressed as meanϮS.E.M. (nϭ3). * * pϽ0.01. toxicity, as demonstrated by MTT and flow cytometry assays (data not shown). These results suggest that corynoxeine has a potent inhibitory effect on PDGF-BB-induced VSMC proliferation and may be useful in the prevention and treatment of vascular diseases and restenosis after angioplasty.
To examine the mechanism underlying the anti-proliferative effect of corynoxeine, PDGF-Rb and its downstream kinases were examined in VSMCs. Many studies have suggested that PDGF is a potent mitogen for VSMCs and that phosphorylation of the PDGF receptor is a part of the early signaling cascade for growth induced by this mitogen. [30] [31] [32] Since previous studies have suggested that some flavonoid compounds, such as luteolin, catechins, EGCG and kaempferol, inhibit PDGF-BB-mediated VSMC proliferation by preventing PDGF receptor phosphorylation. [33] [34] [35] [36] [37] [38] We first determined whether corynoxeine inhibited PDGF-Rb phosphorylation. However, corynoxeine had no significant effect on PDGF-BB-induced PDGF-Rb phosphorylation (Fig. 3A) . Furthermore, since PDGF-Rb phosphorylation activates downstream signaling molecules such as MEK1/2, ERK1/2, Akt and PLCg1, 9) we determined the effect on phosphorylation of these proteins. As shown in Figs. 3B and C, corynoxeine did not significantly decrease the PDGF-BB-induced phosphorylation of PLCg1 and Akt. However, corynoxeine inhibited PDGF-BB-induced ERK1/2 activation (Fig. 3D) , in the same concentration range that inhibited VSMC proliferation and DNA synthesis (Fig. 5) . We next examined whether the inhibitory effect of corynoxeine was induced by blocking MEK1/2, a kinase upstream of ERK1/2. As shown in Fig. 4 , corynoxeine did not inhibit PDGF-BB-stimulated MEK1/2 phosphorylation at 5, 20 and 50 mM. These data indicate that ERK1/2 might be a potential target of the anti-proliferative activity of corynoxeine. MAP kinase is an important player in the early intracellular mitogenic signal transduction for cell growth. Among the MAP kinase family, ERK1/2 has been implicated in proliferation of various cell types. 39) Our results also agreed with another study in which VSMC proliferation was inhibited by fangchinoline via inhibition of ERK1/2 activation.
3) Therefore, these results suggest that blocking of ERK1/2 activation by corynoxeine may be important for its anti-proliferative activity.
Taken together, our study showed that corynoxeine is able to inhibit the PDGF-BB-stimulated proliferation of VSMCs through downregulation of PDGF-BB-induced ERK1/2 activation. Corynoxeine may therefore be able to prevent or treat vascular diseases and restenosis after angioplasty.
